^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    QN-302

    i
    Other names: QN-302, QN302, QN 302, SOP1812, SOP 1812, SOP-1812
    Associations
    News
    Trials
    Company:
    Qualigen Therap
    Drug class:
    G4 selective transcription inhibitor, S100P modulator
    Associations
    News
    Trials